Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest Glioma Stories

2012-01-27 10:30:36

Researchers at UT Southwestern Medical Center have developed what they believe to be the first clinical application of a new imaging technique to diagnose brain tumors. The unique test could preclude the need for surgery in patients whose tumors are located in areas of the brain too dangerous to biopsy. This new magnetic resonance spectroscopy (MRS) technique provides a definitive diagnosis of cancer based on imaging of a protein associated with a mutated gene found in 80 percent of low-...

2012-01-26 17:15:00

DALLAS, Jan. 26, 2012 /PRNewswire-USNewswire/ -- Researchers at UT Southwestern Medical Center have developed what they believe to be the first clinical application of a new imaging technique to diagnose brain tumors. The unique test could preclude the need for surgery in patients whose tumors are located in areas of the brain too dangerous to biopsy. This new magnetic resonance spectroscopy (MRS) technique provides a definitive diagnosis of cancer based on imaging of a protein...

2012-01-24 11:50:37

UCSF Team Develops Methods That May Help Predict Tumor Progression and Improve Treatment Follow-up After people with low-grade glioma, a type of brain cancer, undergo neurosurgery to remove the tumors, they face variable odds of survival – depending largely on how rapidly the cancer recurs. Even though their doctors monitor the tumor closely with sophisticated imaging, it is difficult to determine with certainty whether cancer has returned in a more malignant state that requires...

2012-01-19 20:42:22

A recent analysis of clinical trial results performed by the Radiation Therapy Oncology Group (RTOG) demonstrate that a chromosomal abnormality–specifically, the absence (co-deletion) of chromosomes 1p and 19q–have definitive prognostic and predictive value for managing the treatment of adult patients with pure and mixed anaplastic oligodendrogliomas. The presence of the chromosomal abnormality was associated with a substantially better prognosis and near-doubling of median...

2012-01-10 09:35:00

NAPERVILLE, Ill., Jan. 10, 2012 /PRNewswire/ -- While most people are thinking of their resolutions for the new year, Jenny Crowley Searle is resolving to win her five-year battle with brain cancer. Now communities across the Chicagoland area, Indiana and Arizona are joining together to help this young mother realize this resolution together with a Just4Jen Fundraiser on Feb. 2 in Naperville, Ill., where Jenny spent her childhood. Jenny was first diagnosed with an...

2012-01-05 10:40:00

Wake Forest Baptist Only Center in Southeast to Participate in Clinical Trial WINSTON-SALEM, N.C., Jan. 5, 2012 /PRNewswire-USNewswire/ -- A national clinical trial testing the efficacy of a novel brain tumor vaccine has begun at Wake Forest Baptist Medical Center, the only facility in the Southeast to participate. (Logo: http://photos.prnewswire.com/prnh/20111114/DC06171LOGO) The vaccine will be tested in patients with newly diagnosed glioblastoma multiforme (GBM), the most...

2011-12-19 07:30:00

BETHESDA, Md., Dec. 19, 2011 /PRNewswire/ -- After obtaining confirmatory opinions from multiple experts in patent law, Northwest Biotherapeutics (OTC.BB: NWBO) (NW Bio) today reaffirms that its lead program, applying DCVax(®)-L for treatment of brain cancer, continues to have clear freedom to operate with respect to US Patent 7,939,090 (the '090 patent), recently issued to Cedars Sinai, and licensed to Immunocellular Therapeutics (IMUC)...

2011-12-15 17:55:00

Physicians at the Jefferson Hospital for Neuroscience are tackling a particularly aggressive brain cancer that even surgery, chemotherapy and radiation often fail to treat with a promising new immunotherapy to attack a patientâs tumor with their own cancer cells. Philadelphia (PRWEB) December 15, 2011 Physicians at the Jefferson Hospital for Neuroscience (JHN), the regionâs only dedicated hospital for neuroscience, are tackling a particularly aggressive brain...

2011-12-02 08:00:00

PORTSMOUTH, N.H., Dec. 2, 2011 /PRNewswire/ -- Novocure(TM), a commercial stage private oncology company, has announced that prominent neuro-oncologists at four clinical centers in the U.S. will be the first to provide access to its Tumor Treating Fields (TTFields)(TM) device, NovoTTF-100A System(TM), for the treatment of recurrent glioblastoma multiforme (GBM). GBM is a deadly brain tumor affecting approximately 10,000 Americans each year. The NovoTTF(TM) device, approved by...

2011-12-01 22:30:45

Bright color distinguishes tumor from healthy tissue to improve tumor resection Just 24 hours after Lisa Rek sang at her niece's wedding, her husband Brad was driving her to a local hospital. "The pain got worse. When we got to the emergency room, I said to Brad 'something is just not right,'" Rek remembers. After an MRI showed a suspected tumor, Rek was immediately flown to Seidman Cancer Center at University Hospitals (UH) Case Medical Center, where Andrew Sloan, MD, diagnosed her...